TEVA ▼ -0.4% - Teva Pharmaceutical Industries Limited $TEVA - Teva Announces Successful Pricing of $4.9 billion (Equivalent) Senior Notes Teva Pharmaceutical Industries announced the successful pricing of $4.9 billion in equivalent senior notes, a debt offering that likely reflects the company's need to refinance or raise capital for operational purposes. The stock moved down 0.4% today, a modest decline that suggests investors digested the news with limited immediate concern despite the significant debt issuance. 10-SEP-2026 06:04 AM ET